A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases
The development of broad-spectrum antivirals against human coronaviruses (HCoVs) is critical to combat the current coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants, as well as future outbreaks of emerging CoVs. We ha...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2022-04-01
|
| Seri Bilgileri: | Acta Pharmaceutica Sinica B |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S2211383521002756 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|